Concepedia

Karin M. Luens

KM

Statistics

Publications

6

Citations

484

H-Index

6

Active since

1996

Affiliations

Novartis (China)(Current)

System Biosciences (United States)

Karin M. Luens is an author at Novartis (China) specializing in cell biology, life sciences, and hematology.

Publications per year

1996–1999

6

Publications

6

Thrombopoietin, kit Ligand, and flk2/flt3 Ligand Together Induce Increased Numbers of Primitive Hematopoietic Progenitors From Human CD34+Thy-1+Lin− Cells With Preserved Ability to Engraft SCID-hu Bone

Karin M. Luens, Marilyn Travis, Ben P. Chen et al. · Blood · 1998 · 164 citations · Full text

Life Sciences, Cell Biology, Hematology +16

Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+Thy-1+ cells into rapid division

Lesley Murray, Judy Young, Linda J. Osborne et al. · Experimental Hematology · 1999 · 124 citations · Full text

Life Sciences, Cell Biology, Hematology +13

Bone marrow repopulation by human marrow stem cells after long-term expansion culture on a porcine endothelial cell line.

J Brandt, Anne Galy, Karin M. Luens et al. · PubMed · 1998 · 68 citations

Life Sciences, Biotechnology, Cell Biology +15

A monoclonal antibody recognizing CD43 (leukosialin) initiates apoptosis of human hematopoietic progenitor cells but not stem cells

V Bažil, J Brandt, S Chen et al. · Blood · 1996 · 47 citations · Full text

Life Sciences, Cell Biology, Hematology +10

Optimization of Retroviral Gene Transduction of Mobilized Primitive Hematopoietic Progenitors by Using Thrombopoietin, Flt3, and Kit Ligands and RetroNectin Culture

Lesley Murray, Karin M. Luens, Robert Tushinski et al. · Human Gene Therapy · 1999 · 45 citations

Life Sciences, Cell Biology, Hematology +15

1–5 of 6